Evidence map›Paper›PMID 26428846›Full record

Observational studyCritical care (London, England)2015

Incidence and predisposing factors for the development of disturbed glucose metabolism and DIabetes mellitus AFter Intensive Care admission: the DIAFIC study.

Sofie Van Ackerbroeck, Tom Schepens, Karolien Janssens, Philippe G Jorens, Walter Verbrugghe, Sandra Collet, Viviane Van Hoof, Luc Van Gaal, Christophe De Block

Registry-linked trialAbstract readObservational Study
In one paragraph

Observational study in Critical care (London, England), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02180555 (Incidence and Predisposing Factors for the Development of Glucose Metabolism Disturbances and Diabetes Mellitus After Intensive Care Admission), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02180555 unknown statusnot on this map

Incidence and Predisposing Factors for the Development of Glucose Metabolism Disturbances and Diabetes Mellitus After Intensive Care Admission

TypeobservationalSponsorChristophe De BlockRan2012Enrolled400ConditionsStress Hyperglycemia, Diabetes MellitusArmsOral glucose tolerance test
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Observational
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Glucose Control in the ICU: A Continuing Story.Journal of diabetes science and technology · 2016
    Review
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sofie Van AckerbroeckDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium. sofie.vanackerbroeck@hotmail.com.
Tom SchepensDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium. tom.schepens@uza.be.
Karolien JanssensDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium. jans.karo@gmail.com.
Philippe G JorensDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium. philippe.jorens@uza.be.
Walter VerbruggheDepartment of Critical Care Medicine, Antwerp University Hospital, Edegem, Belgium. walter.verbrugghe@uza.be.
Sandra ColletDepartment of Endocrinology, Diabetology and Metabolism, Antwerp University Hospital, Wilrijkstraat 10, B-2650, Edegem, Belgium. sandra.collet@uza.be.
Viviane Van HoofFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. viviane.vanhoof@uza.be.
Luc Van GaalFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. luc.vangaal@uza.be.
Christophe De BlockFaculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. christophe.deblock@uza.be.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionElevated blood glucose levels during intensive care unit (ICU) stay, so-called stress hyperglycaemia (SH), is a common finding. Its relation with a future diabetes risk is unclear. Our objective was to determine the incidence of disturbed glucose metabolism (DGM) post ICU admission and to identify predictors for future diabetes risk with a focus on stress hyperglycaemia.

methodsThis single center prospective cohort trial (DIAFIC trial) had a study period between September 2011 and March 2013, with follow-up until December 2013. The setting was a mixed medical/surgical ICU in a tertiary teaching hospital in Belgium. 338 patients without known diabetes mellitus were included for analysis. We assessed the level of glucose metabolism disturbance (as diagnosed with a 75 g oral glucose tolerance test (OGTT) and/or HbA1c level) eight months after ICU admission, and investigated possible predictors including stress hyperglycaemia.

resultsIn total 246 patients (73 %) experienced stress hyperglycaemia during the ICU stay. Eight months post-ICU admission, 119 (35 %) subjects had a disturbed glucose metabolism, including 24 (7 %) patients who were diagnosed with diabetes mellitus. A disturbed glucose metabolism tended to be more prevalent in subjects who experienced stress hyperglycaemia during ICU stay as compared to those without stress hyperglycaemia (38 % vs. 28 %, P = 0.065). HbA1c on admission correlated with the degree of stress hyperglycaemia. A diabetes risk score (FINDRISC) (11.0 versus 9.5, P = 0.001), the SAPS3 score (median of 42 in both groups, P = 0.003) and daily caloric intake during ICU stay (197 vs. 222, P = 0.011) were independently associated with a disturbed glucose metabolism.

conclusionsStress hyperglycaemia is frequent in non-diabetic patients and predicts a tendency towards disturbances in glucose metabolism and diabetes mellitus. Clinically relevant predictors of elevated risk included a high FINDRISC score and a high SAPS3 score. These predictors can provide an efficient, quick and inexpensive way to identify patients at risk for a disturbed glucose metabolism or diabetes, and could facilitate prevention and early treatment.

trial registrationAt ClinicalTrials.gov NCT02180555 . Registered 1 July, 2014.

Indexed as

AdolescentAdultAgedAged, 80 and overCritical CareDiabetes MellitusFemaleGlucoseGlucose Tolerance TestGlycated HemoglobinHumansHyperglycemiaIncidenceMaleMiddle AgedProspective StudiesGlucoseGlycated Hemoglobinhemoglobin A1c protein, human

Identifiers

PMID26428846
PMCPMC4591636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.